Haoxi Health Technology Limited
HAOCommunication ServicesNASDAQAdvertising Agencies
Scan Results
Daily timeframeHaoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. With a market capitalization of $776K, it sits in micro-cap territory. The company offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms.
Market Cap
$776,187
Beta
-1.08
P/E (TTM)
—
P/E (Fwd)
—
EPS (TTM)
$-413.45
EPS (Fwd)
—
ROE
-54.1%
ROA
-23.6%
Cash
$10.9M
Total Debt
$1.6M
Free CF
$262,978
52W Change
-99.9%
Annual Financials
Cash vs Debt
Where HAO stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, HAO finished 99.70% below its 150-day moving average ($684.35) and 99.85% below its 200-day moving average ($1329.92). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is HAO overbought or oversold?
At the October 20, 2026 close, HAO's RSI(14) was 21.0, in oversold territory (below 30). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The balance sheet looks solid with $10.9M in cash comfortably exceeding the $1.6M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Annual free cash flow of $263K supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of -54.1% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $12.8M (2021) to $54.8M (2026), reflecting a 327% increase over the period.
The relatively low beta of -1.08 suggests HAO is a less volatile holding compared to the broader index. The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Haoxi Health Technology Limited's trajectory.